Marshall Wace, LLP Schrodinger, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Schrodinger, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 77,172 shares of SDGR stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,172

Holding current value

$1.5 Million

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.05 - $24.02 $1.39 Million - $1.85 Million	77,172 New	77,172 $1.43 Million
Q1 2022 May 16, 2022	SELL	$24.84 - $36.12 $2.95 Million - $4.28 Million	-118,616 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.38 - $59.25 $3.96 Million - $7.03 Million	118,616 New	118,616 $4.13 Million
Q2 2021 Aug 13, 2021	SELL	$59.02 - $78.8 $1.73 Million - $2.31 Million	-29,298 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$64.61 - $113.09 $6.13 Million - $10.7 Million	-94,821 Reduced 76.4%	29,298 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$48.06 - $84.4 $5.97 Million - $10.5 Million	124,119 New	124,119 $9.83 Million
Q3 2020 Nov 16, 2020	SELL	$46.87 - $93.33 $4.88 Million - $9.71 Million	-104,048 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$36.12 - $91.57 $3.76 Million - $9.53 Million	104,048 New	104,048 $9.53 Million

Others Institutions Holding SDGR

# of Institutions

235

Shares Held

60.7M

Call Options Held

726K

Put Options Held

329K

Black Rock Inc. New York, NY

8.52M
Shares

$166 Million
0.0% of portfolio
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa

6.98M
Shares

$136 Million
0.29% of portfolio
Vanguard Group Inc Valley Forge, PA

6.71M
Shares

$130 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

3.69M
Shares

$71.6 Million
1.9% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.34M
Shares

$45.4 Million
0.41% of portfolio

View Full List

About Schrodinger, Inc.

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.21B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

More about SDGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account